Procella Therapeutics is an early stage biotechnology company that develop a cardiac stem cell therapy for patients with advanced heart failure.

T&R Biofab Co., Ltd engages in the manufacture and sale of biomedical equipment. It is specialized in bio-resorable mesh for tissue and organ regeneration. Its products include CMF Mesh, Nasal Mesh, Dental Membrane and Bio-resorable stent. The company was founded on March 11, 2013 and is headquartered in Siheung, South Korea.

Orizuru Therapeutics, Inc. is a Japanese company. The firm operates as a cell-related technology company that provides regenerative medicine and cell transplantation services.

Vestion, Inc. is an American private company located in Miami, FL. The firm provides healthcare services. It was founded by Joshua M. Hare.

BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden.

Sanyo Chemical Industries, Ltd. engages in the manufacture and sale of chemicals. It operates through the following segments: Toiletries and Health Care; Petroleum and Automotives; Plastics and Textiles; Information and Electronics; and Environmental Protection, Construction, and Others. The Toiletries and Health Care segment manufactures and supplies surfactants for detergents, cleaning agents, and toiletries; pharmaceutical additives; and superabsorbent polymers. The Petroleum and Automotives segment develops and distributes thermoplastic polyurethane beads (TUB) for the interior parts of automobiles, raw materials for polyurethane foams, and lubricating oil additives. The Plastics and Textiles segment offers permanent antistatic agents, and carbon fiber and fiberglass agents. The Information and Electronics segment includes polymerization toners, toner binders, and electrolytes for aluminum electrolytic capacitors. The Environmental Protection, Construction, and Others segment manufactures and distributes polymer flocculants for wastewater treatment, and polyurethane insulation raw materials. The company was founded on November 1, 1949 and is headquartered in Kyoto, Japan.

Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

iHeart Japan Corp. operates as a medical research and development firm. It develops therapies that can replace heart transplantation for severe heart failure. The firm applies the iPS cell research and application technology for its therapies. The company was founded by Jun Yamashita on April 18, 2013 and is headquartered in Kyoto, Japan.

Kyowa Hakko Bio Co. Ltd. engages in the manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use. The company was founded on October 1, 2008 and is headquartered in Tokyo, Japan.

Oloker Therapeutics provides discovery, development, and commercialization of cellular therapies. Their research and in-depth knowledge of cardiovascular diseases. The company's contact modes are by mail, phone, and physical address.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Centro Cardiologico Monzino SpA engages in the treatment, research, and study of cardiovascular diseases. Its clinical activities include interventional cardiology, cardiovascular surgery, cardiac imaging, and diagnostic laboratory services. The company was founded by Italo Monzino and Cesare Bartorelli in 1981 and is headquartered in Milan, Italy.

FUJIFILM Holdings America Corp. manufactures and markets photographic, medical imaging and informatics. It offers data storage, graphic arts and printing, industrial materials, inkjet solutions, optical devices, photofinishing products, professional photography, semiconductor materials, and specialty chemicals. The company was founded by Stephen Weinstock and is headquartered in Valhalla, NY.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

Chengnuo Regenerative Medicine Technology (Zhuhai Hengqin New Area) Co., Ltd., established on 2020-12-17, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Cellectis AB, a subsidiary of Takara Holdings, Inc., is a Swedish company located in Gothenburg. The firm manufactures and distributes stem cell-related products. On September 04, 2014 Takara Bio, Inc. acquired Cellectis AB from Cellectis SA.

Guangzhou Medical University New Drug Creation Co., Ltd., established on 2015-08-21, Business scope includes medical research and experimental development;Biomedical Technology Research;Biotechnology Development Services;Biotechnology Transfer Services;drug development;Stem Cell Drug Development;Stem Cell Technology Research,to develop;Health Sciences Program Research Transfer;Technology intermediary service;Biological Products Testing;Clinical Laboratory Services;Manufacturing of chemical raw materials

Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics.